Clark Capital Management Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-317,482	Closed	-$8.5M	–	520
2025 Q4	$8.5M	Buy	317,482 +33,808	+12%	+$871K	0.05%	180
2025 Q3	$7.56M	Buy	+283,674	New	+$7.33M	0.05%	189
2025 Q1	–	Sell	-148,075	Closed	-$5.5M	–	428
2024 Q4	$5.5M	Sell	148,075 -5,672	-4%	-$259K	0.04%	189
2024 Q3	$7.46M	Buy	153,747 +56,337	+58%	+$2.47M	0.05%	163
2024 Q2	$3.9M	Buy	97,410 +57,346	+143%	+$2.38M	0.03%	192
2024 Q1	$1.76M	Sell	40,064 -22,178	-36%	-$1.15M	0.01%	257
2023 Q4	$3.85M	Buy	62,242 +4,237	+7%	+$223K	0.03%	187
2023 Q3	$2.67M	Buy	58,005 +23,373	+67%	+$1.28M	0.03%	196
2023 Q2	$1.99M	Buy	+34,632	New	+$1.54M	0.02%	216
2022 Q3	–	Sell	-68,957	Closed	-$2.4M	–	339
2022 Q2	$2.4M	Sell	68,957 -26,672	-28%	-$952K	0.03%	197
2022 Q1	$3.43M	Buy	95,629 +15,535	+19%	+$441K	0.04%	204
2021 Q4	$1.86M	Buy	+80,094	New	+$1.64M	0.02%	222